The global radiodermatitis market is on a steady growth trajectory, with its size expected to be valued at US$ 461.7 million in 2025 and projected to reach US$ 650.5 million by 2032, advancing at a CAGR of 4.8% during 2025–2032, according to industry analysis. Radiodermatitis, also referred to as radiation-induced dermatitis, is a frequent complication faced by cancer patients undergoing...